Transmission dynamics and risk factors for pandemic H1N1-related illness: Outbreak investigation in a rural community of British Columbia, Canada

Influenza and other Respiratory Viruses

Volumn 6, Issue 3, 2012, Pages

  Janjua, Naveed Z ^a,b   Skowronski, Danuta M ^a,b   Hottes, Travis S ^a   Osei, William ^c   Adams, Evan ^d   Petric, Martin ^a   Lem, Marcus ^e   Tang, Patrick ^a   De Serres, Gaston ^f   Patrick, David M ^a,b   Bowering, David ^c  

^a BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Northern Health Authority   (Canada)

^d MINISTRY OF HEALTH   (Canada)

^e HEALTH CANADA   (Canada)

^f INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

Author keywords

Aboriginal; H1N1 pandemic; Human influenza; Risk factors; Serial interval; Transmission

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADULT; AGED; ARTICLE; CANADA; CHILD; CHRONIC DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE TRANSMISSION; EPIDEMIC; FEMALE; HOUSEHOLD; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIMARY SCHOOL; PRIORITY JOURNAL; RISK FACTOR; RURAL POPULATION; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; BRITISH COLUMBIA; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FAMILY CHARACTERISTICS; FEMALE; HUMANS; INCIDENCE; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PANDEMICS; RISK FACTORS; RURAL POPULATION; SCHOOLS; YOUNG ADULT;

EID: 84859764414     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2012.00344.x     Document Type: Article

References (34)

1. Janjua NZ, Skowronski DM, Hottes TS et al. Seasonal influenza vaccine and increased risk of pandemic A/H1N1-related illness: first detection of the association in British Columbia, Canada. Clin Infect Dis 2010; 51:1017-1027.
2. Skowronski D, De Serres G, Crowcroft N et al. Association between the 2008-2009 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med 2010; 7:e1000258.
3. National Advisory Committee on Immunization (NACI). Statement on Influenza Vaccination for the 2008-2009 Season. Can Commun Dis Rep 2008; 34:1-46.
4. Fine P. The interval between successive cases of an infectious disease. Am J Epidemiol 2003; 158:1039-1047.
5. Cowling B, Fang V, Riley S, Malik Peiris J, Leung G. Estimation of the serial interval of influenza. Epidemiology 2009; 20:344-347.
6. British Columbia First Nations Health Council. Healthy Children, Healthy Families, Healthy Communities: The Road to Wellness. BC First Nations Regional Longitudinal Health Survey 2002/2003. West Vancouver (BC), Canada: British Columbia First Nations Health Council, 2005.
7. Pathways to Health and Healing - 2nd Report on the Health and Well-being of Aboriginal People in British Columbia. Provincial Health Officer's Annual Report 2007. Victoria (BC), Canada: Ministry of Healthy Living and Sport, 2009.
8. Lessler J, Reich NG, Cummings DA, Nair HP, Jordan HT, Thompson N. Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school. N Engl J Med 2009; 361:2628-2636.
9. France AM, Jackson M, Schrag S et al. Household transmission of 2009 influenza A (H1N1) virus after a school-based outbreak in New York City, April-May 2009. J Infect Dis 2010; 201:984-992.
10. Witkop C, Duffy M, Macias E et al. Novel Influenza A (H1N1) outbreak at the U.S. Air Force Academy: epidemiology and viral shedding duration. Am J Prev Med 2010; 38:121-126.
11. Tuite AR, Greer AL, Whelan M et al. Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza. CMAJ 2010; 182:131-136.
12. Suess T, Buchholz U, Dupke S et al. Shedding and transmission of novel influenza virus A/H1N1 infection in households - Germany, 2009. Am J Epidemiol 2010; 171:1157-1164.
13. Ng S, Cowling B, Fang V et al. Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus. Clin Infect Dis 2010; 50:707-714.
14. Hancock K, Veguilla V, Lu X et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361:1945-1952.
15. Sikora C, Fan S, Golonka R et al. Transmission of pandemic influenza A (H1N1) 2009 within households: Edmonton, Canada. J Clin Virol 2010; 49:90-93.
16. Morgan OW, Parks S, Shim T et al. Household transmission of pandemic (H1N1) 2009, San Antonio, Texas, USA, April-May 2009. Emerg Infect Dis 2010; 16:631-637.
17. Zarychanski R, Stuart TL, Kumar A et al. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ 2010; 182:257-264.
18. Campbell A, Rodin R, Kropp R et al. Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza. CMAJ 2010; 182:349-355.
19. Jain S, Kamimoto L, Bramley A et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361: 1935-1944.
20. Centers for Disease Control and Prevention (CDC). Introduction and transmission of 2009 pandemic influenza A (H1N1) Virus - Kenya, June-July 2009. MMWR Morb Mortal Wkly Rep 2009; 58:1143-1146.
21. Papenburg J, Baz M, Hamelin M et al. Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory-confirmed secondary attack rates and evidence of asymptomatic infections. Clin Infect Dis 2010; 51:1033-1041.
22. Yang Y, Sugimoto JD, Halloran ME et al. The transmissibility and control of pandemic influenza A (H1N1) virus. Science 2009; 326:729-733.
23. Odaira F, Takahashi H, Toyokawa T et al. Assessment of secondary attack rate and effectiveness of antiviral prophylaxis among household contacts in an influenza A(H1N1)v outbreak in Kobe, Japan, May-June 2009. Euro Surveill 2009; 14:pii=19320.
24. Calatayud L, Kurkela S, Neave PE et al. Pandemic (H1N1) 2009 virus outbreak in a school in London, April-May 2009: an observational study. Epidemiol Infect 2010; 138:183-191.
25. Doyle T, Hopkins R. Low secondary transmission of 2009 pandemic influenza A (H1N1) in households following an outbreak at a summer camp: relationship to timing of exposure. Epidemiol Infect 2010; 139:1-7.
26. Goldstein E, Cowling B, O'Hagan J et al. Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009. BMC Infect Dis 2010; 10:211.
27. Hayden F, Belshe R, Villanueva C et al. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. J Infect Dis 2004; 189:440-449.
28. Ling L, Chow A, Lye D et al. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. Clin Infect Dis 2010; 50:963-969.
29. Bansal S, Pourbohloul B, Hupert N, Grenfell B, Meyers L. The shifting demographic landscape of pandemic influenza. PLoS ONE 2010; 5:e9360.
30. Wallinga J, Lipsitch M. How generation intervals shape the relationship between growth rates and reproductive numbers. Proc Biol Sci 2007; 274:599-604.
31. Fraser C, Riley S, Anderson R, Ferguson N. Factors that make an infectious disease outbreak controllable. Proc Natl Acad Sci U S A 2004; 101:6146-6151.
32. Cauchemez S, Donnelly CA, Reed C et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med 2009; 361:2619-2627.
33. Cowling BJ, Chan KH, Fang VJ et al. Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med 2010; 362:2175-2184.
34. McBryde E, Bergeri I, Van Gemert C et al. Early transmission characteristics of influenza A(H1N1)v in Australia: Victorian state, 16 May - 3 June 2009. Euro Surveill 2009; 14:pii=19363.